Calcium antagonists and cardiovascular events in patients with hypertension and diabetes

被引：21

作者：

Alderman, M ^{[1
]}

Madhavan, S ^{[1
]}

Cohen, H ^{[1
]}

机构：

[1] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA

来源：

LANCET | 1998年 / 351卷 / 9097期

关键词：

D O I：

10.1016/S0140-6736(05)78175-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：216 / 217

页数：2

相关论文

共 4 条

[1] Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
Alderman, MH
Cohen, H
Roque, R
Madhavan, S
[J]. LANCET, 1997, 349 (9052) : 594 - 598
[2] Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) - A randomized controlled trial
Borhani, NO
Mercuri, M
Borhani, PA
Buckalew, VM
CanossaTerris, M
Carr, AA
Kappagoda, T
Rocco, MV
Schnaper, HW
Sowers, JR
Bond, MG
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (10): : 785 - 791
[3] Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events
Byington, RP
Craven, TE
Furberg, CD
Pahor, M
[J]. LANCET, 1997, 350 (9084) : 1075 - 1076
[4] TATTI P, 1997, NOV 12 1997 AM HEART